Aug 17, 2022 | International Laboratory News, Laboratory News, Laboratory Pathology, Laboratory Testing, Precision Medicine
Study may lead to clinical laboratory involvement in repurposing hormonal treatments to prevent cancer treatment resistance Diagnosing prostate cancer and identifying which patients have aggressive forms of the cancer has been a challenge. But new insights into how aggressive cancers become resistant to drug therapies—and the discovery of a way to repurpose hormonal treatment to block or slow aggressive prostate cancer—may lead to clinical laboratories monitoring the progress of patients’...